Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial

Haematologica - Italy
doi 10.3324/haematol.2015.135418
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)


Related search